Medienmitteilung

Value of Text Verification Tool (TVT) Strongly Confirmed at RAPS in Philadelphia

Frankfurt (ots) -

Trying economic times mean tight budgets. More
projects, fewer people, rigid quality standards and competitve 
pressures are making the computer-driven proofreading tool made by 
Schlafender Hase more valuable than ever.

Schlafender Hase GmbH of Frankfurt reported that an analyis of 
discussions with professionals attending the annually RAPS event 
(Regulatory Affairs Professionals Society) in Philadelphia showed 
they often spend more time doing what they can't do than what they 
can do.

TVT shifts the focus from proofreading to pharmaceuticals

"Much of time-intensive proofreading activities in the regulatory 
afffairs context have little to do with pharmaceuticals," explained 
Willie Schnaubelt, managing director at Schlafender Hase. "Questions 
about misspelling and inconsistencies in layouts are robbing people 
of time that could be better spent on pharmaceutical issues. TVT 
makes it possible to win time for doing what they can do best, by not
losing time doing proofreading chores that their computer can do more
effectivly."

The human element was also a focal point at RAPS. While all agreed
about the importance of flawless documentation, frustration was also 
expressed about the degree to which pharmaceutical skills often took 
a back seat to proofreading needs. As one RAPS visitor put it: 
"Sometimes I'm evaluated as a proofreader and not as a 
pharmaceuticals professional. It is an unfair situation, both to me 
and the product. I look to TVT as a way out of this dilemma."

About TVT

TVT is the standard for the pharmaceutical industry. It supports 
all relevant file formats (DOC, DOCX RTF, TXT, HTML, PDF and both 
XML-standards PIM and SPL) and processes all major languages.

For more information about TVT and Schlafender Hase contact:
Willie Schnaubelt, 
EU: +49 69 2444-8112 
US: +1 973 685-6123 
www.text-verification.com

Permalink:

https://www.presseportal.ch/de/pm/100013798/100590267